US Patent 10040853 Methods and compositions involving NKG2D inhibitors and cancer
Patent 10040853 was granted and assigned to Fred Hutchinson Cancer Research Center on August, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10040853 Methods and compositions involving NKG2D inhibitors and cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.